CHAPTER 13: AGENTS USED TO TREAT HYPERURICEMIA AND GOUT

CHAPTER 13: AGENTS USED TO TREAT HYPERURICEMIA AND GOUT

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

MULTIPLE CHOICE

 

1. The nurse understands the most common joint to be affected by hyperuricemia is the:

a.	metacarpal phalangeal joint.	c.	elbow joint.
b.	ankle joint.	d.	metatarsophalangeal joint.

 

 

ANS:  D

 

	Feedback
A	Incorrect: These are finger joints.
B	Incorrect: This is not the most common site.
C	Incorrect: This is not the most common site.
D	Correct: The metatarsophalangeal joint in the great toe is the most common site.

 

 

PTS:   1                    REF:   p. 353            OBJ:   Cognitive Level: Knowledge

 

2. Which of the following statements is not true?

a.	Gout affects men and women equally.
b.	About 25% of all close relatives of persons with gout exhibit hyperuricemia.
c.	About 2.1 million individuals in the United States have gout.
d.	Gout usually first appears in middle age.

 

 

ANS:  A

 

	Feedback
A	Correct: Ninety percent of gout sufferers are men.
B	Incorrect: This is a true statement.
C	Incorrect: This is a true statement.
D	Incorrect: This is a true statement.

 

 

PTS:   1                    REF:   p. 352            OBJ:   Cognitive Level: Knowledge

 

3. Allopurinol acts to treat hyperuricemia by:

a.	preventing the formation of uric acid in the body.
b.	increasing urinary excretion of uric acid.
c.	preventing the reabsorption of uric acid in the renal tubules.
d.	preventing the formation of urate stones in the kidney.

 

 

ANS:  A

 

	Feedback
A	Correct: Allopurinol prevents the formation of uric acid in the body.
B	Incorrect: Allopurinol does not increase urinary excretion of uric acid.
C	Incorrect: This is the same as answer b.
D	Incorrect: Although allopurinol does prevent urate stones, this is not its pharmacotherapeutic action.

 

 

PTS:   1                    REF:   p. 355            OBJ:   Cognitive Level: Knowledge

 

4. An agent that increases uric acid excretion and prevents blood clot formation is:

a.	colchicine.	c.	probenecid.
b.	allopurinol.	d.	sulfinpyrazone.

 

 

ANS:  D

 

	Feedback
A	Incorrect: Colchicine does not affect platelet function.
B	Incorrect: Allopurinol does not affect platelet function.
C	Incorrect: Probenecid does not affect platelet function.
D	Correct: Sulfinpyrazone alters platelet function preventing blood clot formation.

 

 

PTS:   1                    REF:   p. 355            OBJ:   Cognitive Level: Knowledge

 

5. An agent used to treat gout that can inhibit the excretion of penicillin is:

a.	allopurinol.	c.	probenecid.
b.	colchicine.	d.	sulfinpyrazone.

 

 

ANS:  C

 

	Feedback
A	Incorrect: Allopurinol does not inhibit penicillin excretion.
B	Incorrect: Colchicine does not inhibit penicillin excretion.
C	Correct: Probenecid inhibits penicillin excretion, so it raises the level of penicillin in the body.
D	Incorrect: Sulfinpyrazone does not inhibit penicillin excretion.

 

 

PTS:   1                    REF:   p. 355            OBJ:   Cognitive Level: Knowledge